Research Progress of Natural Components Improving Parkinson's Disease by Regulating the Oxidative Stress

Fuente: Wiley Open Access
Enregistré dans:
Détails bibliographiques
Auteurs principaux: Wei Jiang, Zifa Li, Minghui Hu, Hao Zhang, Xuanhe Tian, Qiuyue Chen, Yue Zhao, Kaiyong Xu, Yuanjun Qu, Sheng Wei, Xinyu Wang, Xiwen Geng
Format: Artículo Open Access
Publié: Wiley 2026
Sujets:
Accès en ligne:
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
_version_ 1867012706619359232
author Wei Jiang
Zifa Li
Minghui Hu
Hao Zhang
Xuanhe Tian
Qiuyue Chen
Yue Zhao
Kaiyong Xu
Yuanjun Qu
Sheng Wei
Xinyu Wang
Xiwen Geng
author_facet Wei Jiang
Zifa Li
Minghui Hu
Hao Zhang
Xuanhe Tian
Qiuyue Chen
Yue Zhao
Kaiyong Xu
Yuanjun Qu
Sheng Wei
Xinyu Wang
Xiwen Geng
Wei Jiang
Zifa Li
Minghui Hu
Hao Zhang
Xuanhe Tian
Qiuyue Chen
Yue Zhao
Kaiyong Xu
Yuanjun Qu
Sheng Wei
Xinyu Wang
Xiwen Geng
collection Wiley Open Access
contents Research Progress of Natural Components Improving Parkinson's Disease by Regulating the Oxidative Stress Wei Jiang Zifa Li Minghui Hu Hao Zhang Xuanhe Tian Qiuyue Chen Yue Zhao Kaiyong Xu Yuanjun Qu Sheng Wei Xinyu Wang Xiwen Geng Phytotherapy Research ABSTRACT Parkinson's disease (PD), the second most prevalent neurodegenerative disorder globally, places a considerable burden on patients because of its progressive and disabling course. Although current pharmacological treatments offer only transient symptomatic relief and do not effectively arrest the underlying disease process, oxidative stress has been recognized as a pivotal contributor to PD pathogenesis and thus represents a key therapeutic target. Over the past decade, a growing body of evidence has indicated that selected natural compounds can ameliorate PD‐related manifestations by modulating oxidative stress. Their putative neuroprotective actions and associated molecular mechanisms have been partially characterized in preclinical investigations, including in vitro cell models and in vivo animal studies. Nevertheless, the majority of current studies on these natural components are still confined to the preclinical setting, and their clinical efficacy has yet to be substantiated by rigorous, high‐quality evidence. Robust randomized controlled trials with multicenter participation, adequate sample sizes, and extended follow‐up are urgently required to facilitate their safe and effective translation into clinical practice. This review highlights natural compounds, including polyphenols, flavonoids, glycosides, terpenoids, and alkaloids, and synthesizes current knowledge regarding their neuroprotective potential and mechanisms, with the goal of informing future PD‐focused research on natural products and guiding the development of novel therapeutic strategies. 10.1002/ptr.70214 http://onlinelibrary.wiley.com/termsAndConditions#vor
doi_str_mv 10.1002/ptr.70214
format Artículo Open Access
id wiley_oa_10_1002_ptr_70214
institution Wiley Open Access
license_str_mv http://onlinelibrary.wiley.com/termsAndConditions#vor
publishDate 2026
publisher Wiley
record_format wiley_oa
spellingShingle Research Progress of Natural Components Improving Parkinson's Disease by Regulating the Oxidative Stress
Wei Jiang
Zifa Li
Minghui Hu
Hao Zhang
Xuanhe Tian
Qiuyue Chen
Yue Zhao
Kaiyong Xu
Yuanjun Qu
Sheng Wei
Xinyu Wang
Xiwen Geng
Phytotherapy Research
Research Progress of Natural Components Improving Parkinson's Disease by Regulating the Oxidative Stress Wei Jiang Zifa Li Minghui Hu Hao Zhang Xuanhe Tian Qiuyue Chen Yue Zhao Kaiyong Xu Yuanjun Qu Sheng Wei Xinyu Wang Xiwen Geng Phytotherapy Research ABSTRACT Parkinson's disease (PD), the second most prevalent neurodegenerative disorder globally, places a considerable burden on patients because of its progressive and disabling course. Although current pharmacological treatments offer only transient symptomatic relief and do not effectively arrest the underlying disease process, oxidative stress has been recognized as a pivotal contributor to PD pathogenesis and thus represents a key therapeutic target. Over the past decade, a growing body of evidence has indicated that selected natural compounds can ameliorate PD‐related manifestations by modulating oxidative stress. Their putative neuroprotective actions and associated molecular mechanisms have been partially characterized in preclinical investigations, including in vitro cell models and in vivo animal studies. Nevertheless, the majority of current studies on these natural components are still confined to the preclinical setting, and their clinical efficacy has yet to be substantiated by rigorous, high‐quality evidence. Robust randomized controlled trials with multicenter participation, adequate sample sizes, and extended follow‐up are urgently required to facilitate their safe and effective translation into clinical practice. This review highlights natural compounds, including polyphenols, flavonoids, glycosides, terpenoids, and alkaloids, and synthesizes current knowledge regarding their neuroprotective potential and mechanisms, with the goal of informing future PD‐focused research on natural products and guiding the development of novel therapeutic strategies. 10.1002/ptr.70214 http://onlinelibrary.wiley.com/termsAndConditions#vor
title Research Progress of Natural Components Improving Parkinson's Disease by Regulating the Oxidative Stress
topic Phytotherapy Research
url https://onlinelibrary.wiley.com/doi/10.1002/ptr.70214